Genscript Biotech Corporation (1548.HK)

HKD 10.62

(1.92%)

Long Term Debt Summary of Genscript Biotech Corporation

  • Genscript Biotech Corporation's latest annual long term debt in 2023 was 351.11 Million USD , down -38.1% from previous year.
  • Genscript Biotech Corporation's latest quarterly long term debt in 2024 Q2 was 846.14 Million USD , up 194.61% from previous quarter.
  • Genscript Biotech Corporation reported annual long term debt of 567.22 Million USD in 2022, up 48.54% from previous year.
  • Genscript Biotech Corporation reported annual long term debt of 381.86 Million USD in 2021, up 30206.35% from previous year.
  • Genscript Biotech Corporation reported quarterly long term debt of 351.11 Million USD for 2023 FY, down -38.1% from previous quarter.
  • Genscript Biotech Corporation reported quarterly long term debt of 351.11 Million USD for 2023 Q4, down -54.47% from previous quarter.

Annual Long Term Debt Chart of Genscript Biotech Corporation (2023 - 2013)

Historical Annual Long Term Debt of Genscript Biotech Corporation (2023 - 2013)

Year Long Term Debt Long Term Debt Growth
2023 351.11 Million USD -38.1%
2022 567.22 Million USD 48.54%
2021 381.86 Million USD 30206.35%
2020 1.26 Million USD -27.92%
2019 1.74 Million USD 143.5%
2018 -4.01 Million USD -39.18%
2017 -2.88 Million USD -22.9%
2016 -2.34 Million USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%

Peer Long Term Debt Comparison of Genscript Biotech Corporation

Name Long Term Debt Long Term Debt Difference
Uni-Bio Science Group Limited 30.61 Million HKD -1046.975%
CK Life Sciences Int'l., (Holdings) Inc. 4.27 Billion HKD 91.783%